A Comparison of Outcomes With Apixaban, Rivaroxaban, and Warfarin for Atrial Fibrillation and/or Venous Thromboembolism | JACC: Advances
- Author
- American College of Cardiology
- Published
- Wed 28 May 2025
- Episode Link
- https://traffic.libsyn.com/jacccepaudio/JACCADV_4-5_brahmbhatt_052825_13.mp3
Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on A Comparison of Outcomes With Apixaban, Rivaroxaban, and Warfarin for Atrial Fibrillation and/or Venous Thromboembolism.
